As of January 2025, Harbin Gloria Pharmaceuticals has a market cap of $744.16M. This makes Harbin Gloria Pharmaceuticals the world's 9169th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $593.52M | -21.51% |
2023 | $756.21M | -1.18% |
2022 | $765.24M | -12.71% |
2021 | $876.72M | -9.06% |
2020 | $964.09M | 5.61% |
2019 | $912.87M | 8.21% |
2018 | $843.58M | -59.36% |
2017 | $2.08B | -16.69% |
2016 | $2.49B | -17.98% |
2015 | $3.04B | 27.37% |
2014 | $2.39B | 41.03% |
2013 | $1.69B | 108.00% |
2012 | $813.05M | - |